Sinotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	225.79	641.79	763.15	511.66
Short-Term Investments	-	-	107.21	44.09	-
Trading Asset Securities	-	507.74	-	-	-
Cash & Short-Term Investments	765.54	733.53	749	807.23	511.66
Cash Growth	4.36%	-2.07%	-7.21%	57.77%	17.85%
Accounts Receivable	-	110.97	78.47	71.27	44.09
Other Receivables	-	0.3	0.57	-	-
Receivables	-	111.27	79.04	71.27	44.09
Inventory	-	102.42	84.61	29.38	40.43
Other Current Assets	-	29.1	39.36	45.83	22.66
Total Current Assets	-	976.32	952.01	953.71	618.83
Property, Plant & Equipment	-	344.34	271.41	255.92	115.09
Long-Term Investments	-	64.42	64.2	49.1	69.99
Goodwill	-	18.39	18.39	18.39	-
Other Intangible Assets	-	21.65	27.59	32.47	41.16
Long-Term Deferred Tax Assets	-	19.33	14.29	16.45	16.08
Long-Term Deferred Charges	-	0.92	1.21	1.99	3.15
Other Long-Term Assets	-	7.94	12.54	4.3	1.5
Total Assets	-	1,453	1,362	1,332	865.81
Accounts Payable	-	16.75	13.34	8.42	8.01
Accrued Expenses	-	26.49	14.69	11.58	14.19
Current Portion of Leases	-	0.01	0.06	0.32	0.78
Current Income Taxes Payable	-	6.97	1.28	0.45	7.85
Current Unearned Revenue	-	30.44	48.01	56.8	46.78
Other Current Liabilities	-	22.54	13.33	12.47	11.92
Total Current Liabilities	-	103.19	90.72	90.05	89.52
Long-Term Leases	-	-	0.02	1.2	3.66
Long-Term Unearned Revenue	-	74.72	58.09	61.12	64.62
Long-Term Deferred Tax Liabilities	-	2.39	2.53	2.68	2.82
Total Liabilities	-	180.3	151.36	155.05	160.62
Common Stock	-	453.34	453.34	453.34	408
Additional Paid-In Capital	-	513.57	512.89	512.89	179.23
Retained Earnings	-	342.22	244.16	211.19	118.26
Treasury Stock	-	-36.13	-	-	-
Comprehensive Income & Other	-	-	-0.13	-0.15	-0.31
Shareholders' Equity	1,308	1,273	1,210	1,177	705.19
Total Liabilities & Equity	-	1,453	1,362	1,332	865.81
Total Debt	0.02	0.01	0.09	1.52	4.44
Net Cash (Debt)	765.52	733.53	748.92	805.71	507.22
Net Cash Growth	4.36%	-2.05%	-7.05%	58.85%	16.82%
Net Cash Per Share	1.72	1.61	1.59	1.91	1.24
Filing Date Shares Outstanding	419.96	449	449.15	453.34	408
Total Common Shares Outstanding	449	449	453.34	453.34	408
Working Capital	-	873.13	861.29	863.66	529.31
Book Value Per Share	2.91	2.84	2.67	2.60	1.73
Tangible Book Value	1,273	1,233	1,164	1,126	664.02
Tangible Book Value Per Share	2.84	2.75	2.57	2.48	1.63
Buildings	-	216.23	211.68	54.29	52.41
Machinery	-	183.49	160.89	145.6	135.93
Construction In Progress	-	80.75	15.35	153.61	4.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.